Unknown

Dataset Information

0

CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function.


ABSTRACT: While effective in specific settings, adoptive chimeric antigen receptor (CAR) T cell therapy for cancer requires further improvement and optimization. Our previous results show that CD40L-overexpressing CAR T cells mobilize endogenous immune effectors, resulting in improved antitumor immunity. However, the cell populations required for this protective effect remain to be identified. Here we show, by analyzing Batf3-/- mice lacking the CD103+ conventional dendritic cell type 1 (cDC1) subpopulation important for antigen cross-presentation, that CD40L-overexpressing CAR T cells elicit an impaired antitumor response in the absence of cDC1s. We further find that CD40L-overexpressing CAR T cells stimulate tumor-resident CD11b-CD103- double-negative (DN) cDCs to proliferate and differentiate into cDC1s in wild-type mice. Finally, re-challenge experiments show that endogenous CD8+ T cells are required for protective antitumor memory in this setting. Our findings thus demonstrate the stimulatory effect of CD40L-overexpressing CAR T cells on innate and adaptive immune cells, and provide a rationale for using CD40L-overexpressing CAR T cells to improve immunotherapy responses.

SUBMITTER: Kuhn NF 

PROVIDER: S-EPMC7710757 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

CD103<sup>+</sup> cDC1 and endogenous CD8<sup>+</sup> T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function.

Kuhn Nicholas F NF   Lopez Andrea V AV   Li Xinghuo X   Cai Winson W   Daniyan Anthony F AF   Brentjens Renier J RJ  

Nature communications 20201202 1


While effective in specific settings, adoptive chimeric antigen receptor (CAR) T cell therapy for cancer requires further improvement and optimization. Our previous results show that CD40L-overexpressing CAR T cells mobilize endogenous immune effectors, resulting in improved antitumor immunity. However, the cell populations required for this protective effect remain to be identified. Here we show, by analyzing Batf3<sup>-/-</sup> mice lacking the CD103<sup>+</sup> conventional dendritic cell typ  ...[more]

Similar Datasets

| S-EPMC3897504 | biostudies-literature
| S-EPMC7017236 | biostudies-literature
| S-EPMC10694434 | biostudies-literature
| S-EPMC6981069 | biostudies-literature
| S-EPMC6667789 | biostudies-literature
| S-EPMC5214764 | biostudies-literature
| S-EPMC10565384 | biostudies-literature
| S-EPMC7445430 | biostudies-literature
| S-EPMC8758178 | biostudies-literature
| S-EPMC6308161 | biostudies-literature